Harmony Biosciences CMO exercises 18,750 RSUs

Harmony Biosciences Holdings, Inc. chief medical officer Kumar Budur exercised 18,750 restricted stock units into common stock and had 8,882 shares withheld by the company to cover income tax obligations tied to the vesting.

Rhea-AI Filing Summary

Harmony Biosciences Holdings, Inc. chief medical officer Kumar Budur exercised 18,750 restricted stock units into common stock and had 8,882 shares withheld by the company to cover income tax obligations tied to the vesting. These are compensation-related, non‑market transactions rather than open‑market buying or selling.

Following the transactions, Budur directly owns 24,115 shares of common stock. The filing also corrects previously misstated common stock and derivative holdings, and confirms that the RSU award granted on May 1, 2024 vests in four equal annual installments beginning May 1, 2025.

Insider Trade Summary

18,750 shares exercised/converted

Exercise 3 txns

Insider Budur Kumar

Role CHIEF MEDICAL OFFICER

Type	Security	Shares	Price	Value
Exercise	Restricted Stock Units	18,750	$0.00	$0.00
Exercise	Common Stock	18,750	$0.00	$0.00
Exercise Price or Tax Liability	Common Stock	8,882	$31.83	$283K

Holdings After Transaction: Restricted Stock Units — 37,500 contracts (Direct); Common Stock — 24,115 shares (Direct)

Footnotes (3)

1. F1. The reporting person's previous Form 4 filed on January 26, 2026 inadvertently misstated the number of shares of common stock and derivatives beneficially owned following the transactions reported therein, and that the number has been corrected in the current filing.
2. F2. Shares withheld by the Issuer to satisfy required income tax withholdings pursuant to the vesting of restricted stock units on their scheduled vesting date.
3. F3. The award of restricted stock units was previously granted on May 1, 2024 and shall vest in four equal annual installments beginning on May 1, 2025, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date.

Key Figures

RSUs exercised: 18,750 units Shares withheld for taxes: 8,882 shares Common shares owned after transactions: 24,115 shares +2 more

5 metrics

RSUs exercised 18,750 units Restricted stock units converted to common stock on May 1, 2026

Shares withheld for taxes 8,882 shares Common shares withheld to satisfy income tax withholdings

Common shares owned after transactions 24,115 shares Direct common stock holdings following reported Form 4 transactions

Exercise transactions count 1 transaction Derivative exercise or conversion events in this Form 4

Tax withholding transactions count 1 transaction Share withholding events to cover income tax liability

Key Terms

restricted stock units, income tax withholdings, derivative security, beneficially owned, +1 more

5 terms

restricted stock units financial

"The award of restricted stock units was previously granted on May 1, 2024 and shall vest in four equal annual installments"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

income tax withholdings financial

"Shares withheld by the Issuer to satisfy required income tax withholdings pursuant to the vesting of restricted stock units"

derivative security financial

"transaction_code_description: Exercise or conversion of derivative security"

A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.

beneficially owned financial

"inadvertently misstated the number of shares of common stock and derivatives beneficially owned following the transactions"

Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.

vesting date financial

"restricted stock units was previously granted on May 1, 2024 and shall vest in four equal annual installments beginning on May 1, 2025, subject to continued service through each applicable vesting date"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Harmony Biosciences (HRMY) CMO Kumar Budur report in this Form 4?

Kumar Budur reported exercising 18,750 restricted stock units into common stock. In connection with this vesting, 8,882 shares were withheld by the company for income tax obligations, and his direct common stock holdings were updated to 24,115 shares.

Did the Harmony Biosciences (HRMY) CMO sell shares on the open market?

The transactions were not open-market sales. Shares were withheld by the issuer to satisfy required income tax withholdings tied to RSU vesting, which is a standard, non-market mechanism rather than a discretionary sale decision in the open market.

How many Harmony Biosciences (HRMY) shares does the CMO hold after these transactions?

After the reported transactions, Kumar Budur directly owns 24,115 shares of Harmony Biosciences common stock. This figure reflects the RSU conversion into common shares and the shares withheld by the company for income tax obligations associated with the vesting.

What are the key details of the Harmony Biosciences (HRMY) RSU award?

The restricted stock units were granted on May 1, 2024 and vest in four equal annual installments starting May 1, 2025. Each RSU represents a contingent right to receive one share of common stock and, as disclosed, the award has no stated expiration date.

Why were 8,882 Harmony Biosciences (HRMY) shares withheld from the CMO?

The 8,882 shares were withheld by Harmony Biosciences to satisfy required income tax withholdings upon RSU vesting. This withholding method allows the company to remit taxes on the executive’s behalf without requiring a separate cash payment from the executive.

Did this Harmony Biosciences (HRMY) filing correct any prior reporting errors?

Yes. The filing states that a prior Form 4 dated January 26, 2026 misstated the number of common shares and derivatives beneficially owned after those transactions, and confirms that the ownership figures have been corrected in the current report.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/18/2026 - 04:14 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Budur Kumar

(Last) (First) (Middle)

630 W GERMANTOWN PIKE

(Street)

PLYMOUTH MEETING PENNSYLVANIA 19462

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Harmony Biosciences Holdings, Inc. [ HRMY ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	CHIEF MEDICAL OFFICER

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	05/01/2026		M		18,750	A	$0	32,997(1)	D
Common Stock(2)	05/01/2026		F		8,882	D	$31.83	24,115	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	(3)	05/01/2026		M			18,750	(3)	(3)	Common Stock	18,750	$0	37,500(1)	D

Explanation of Responses:

1. The reporting person's previous Form 4 filed on January 26, 2026 inadvertently misstated the number of shares of common stock and derivatives beneficially owned following the transactions reported therein, and that the number has been corrected in the current filing.

2. Shares withheld by the Issuer to satisfy required income tax withholdings pursuant to the vesting of restricted stock units on their scheduled vesting date.

3. The award of restricted stock units was previously granted on May 1, 2024 and shall vest in four equal annual installments beginning on May 1, 2025, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date.

	/s/ Christian Ulrich, Attorney-in-Fact	05/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)